Lin, Kon-Ping
2 papers on CoChat
Most cited papers
- Verified
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
Adams, D., Gonzalez-Duarte, A., O’Riordan, W. D., Yang, C.-C., Ueda, M., Kristen, A. V., Tournev, I., Schmidt, H. H., Coelho, T., Berk, J. L., et al. (2018) · New England Journal of Medicine
Amyloidosis: Diagnosis, Treatment, OutcomesAlzheimer's disease research and treatments
Cited by 3,047
- Verified
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study
Adams, D., Polydefkis, M., González-Duarte, A., Wixner, J., Kristen, A. V., Schmidt, H. H., Berk, J. L., Losada López, I. A., Dispenzieri, A., Quan, D., et al. (2021) · The Lancet Neurology
Amyloidosis: Diagnosis, Treatment, OutcomesAlzheimer's disease research and treatments
Cited by 158
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free